Literature DB >> 29371393

RESPIRE: breathing new life into bronchiectasis.

Sanjay H Chotirmall1, James D Chalmers2.   

Abstract

Mesh：

Substances：

Year:  2018        PMID： 29371393     DOI： 10.1183/13993003.02444-2017

Source DB:  PubMed          Journal:  Eur Respir J        ISSN： 0903-1936            Impact factor:   16.671


× No keyword cloud information.
  14 in total

1.  Validation of the COPD Assessment Test (CAT) as an Outcome Measure in Bronchiectasis.

Authors:  Simon Finch; Irena F Laska; Hani Abo-Leyah; Thomas C Fardon; James D Chalmers
Journal:  Chest       Date:  2019-11-12       Impact factor: 9.410

Review 2.  Clinical Aspergillus Signatures in COPD and Bronchiectasis.

Authors:  Pei Yee Tiew; Kai Xian Thng; Sanjay H Chotirmall
Journal:  J Fungi (Basel)       Date:  2022-05-05

3.  Bronchiectasis: an emerging global epidemic.

Authors:  Sanjay H Chotirmall; James D Chalmers
Journal:  BMC Pulm Med       Date:  2018-05-22       Impact factor: 3.317

Review 4.  Emerging therapies against infections with Pseudomonas aeruginosa.

Authors:  Burkhard Tümmler
Journal:  F1000Res       Date:  2019-08-07

Review 5.  Bronchiectasis insanity: Doing the same thing over and over again and expecting different results?

Authors:  Mark Metersky; James Chalmers
Journal:  F1000Res       Date:  2019-03-15

6.  Pulmonary rehabilitation after exacerbation of bronchiectasis: a pilot randomized controlled trial.

Authors:  James D Chalmers; Megan L Crichton; Gill Brady; Simon Finch; Mike Lonergan; Thomas C Fardon
Journal:  BMC Pulm Med       Date:  2019-05-06       Impact factor: 3.317

7.  Efficacy of inhaled ciprofloxacin agents for the treatment of bronchiectasis: a systematic review and meta-analysis of randomized controlled trials.

Authors:  Jeong Uk Lim; Seung Wook Hong; Jae-Hoon Ko
Journal:  Ther Adv Respir Dis       Date:  2019 Jan-Dec       Impact factor: 4.031

Review 8.  Bronchiectasis and cough: An old relationship in need of renewed attention.

Authors:  Micheál Mac Aogáin; Sanjay Haresh Chotirmall
Journal:  Pulm Pharmacol Ther       Date:  2019-06-06       Impact factor: 3.410

Review 9.  Control of the Lung Residence Time of Highly Permeable Molecules after Nebulization: Example of the Fluoroquinolones.

Authors:  Julien Brillault; Frédéric Tewes
Journal:  Pharmaceutics       Date:  2020-04-23       Impact factor: 6.321

Review 10.  Hot topics and current controversies in non-cystic fibrosis bronchiectasis.

Authors:  Diego Severiche-Bueno; Enrique Gamboa; Luis F Reyes; Sanjay H Chotirmall
Journal:  Breathe (Sheff)       Date:  2019-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.